Supriya Lifescience Complete Financial Statements
SUPRIYA • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Supriya Lifescience (SUPRIYA).
Downloads include all available records across all periods.
For market performance, see the
SUPRIYA stock price today
.
Profitability Ratios
Net Profit Margin
26.63%
2025 data
EBITDA Margin
38.39%
2025 data
Operating Margin
37.00%
2025 data
Return on Assets
16.91%
2025 data
Return on Equity
18.86%
2025 data
Balance Sheet Ratios
Current Ratio
13.24
2025 data
Debt to Equity
1.12
2025 data
Equity Ratio
89.66%
2025 data
Asset Turnover
0.63
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+2.7%
Year-over-Year
Net Profit Growth
-3.2%
Year-over-Year
EBITDA Growth
-0.7%
Year-over-Year
Expense Growth
+4.8%
Year-over-Year
Assets Growth
+20.7%
Year-over-Year
Equity Growth
+22.3%
Year-over-Year
Liabilities Growth
+20.7%
Year-over-Year
Operating Cash Flow Growth
+46.0%
Year-over-Year
Investing Cash Flow Growth
+12.6%
Year-over-Year
Financing Cash Flow Growth
+63.6%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 725 | 706 | 581 | 470 | 538 | 396 | 323 | 286 | 222 | 191 | 172 | 140 |
| Expenses | 457 | 436 | 397 | 332 | 316 | 218 | 213 | 213 | 191 | 166 | 150 | 121 |
| EBITDA | 269 | 271 | 184 | 138 | 222 | 178 | 110 | 73 | 31 | 25 | 22 | 20 |
| Operating Profit Margin % | 36.00% | 37.00% | 30.00% | 28.00% | 40.00% | 44.00% | 32.00% | 23.00% | 10.00% | 9.00% | 12.00% | 12.00% |
| Depreciation | 24 | 20 | 16 | 12 | 10 | 7 | 6 | 5 | 5 | 5 | 4 | 3 |
| Interest | 2 | 2 | 2 | 3 | 4 | 4 | 7 | 10 | 11 | 12 | 10 | 7 |
| Profit Before Tax | 242 | 249 | 166 | 124 | 207 | 167 | 96 | 57 | 15 | 8 | 8 | 10 |
| Tax | 52 | 61 | 47 | 34 | 55 | 44 | 23 | 18 | 6 | 2 | 2 | 2 |
| Net Profit | 182 | 188 | 119 | 90 | 152 | 124 | 73 | 39 | 9 | 6 | 6 | 8 |
| Earnings Per Share (₹) | 22.70 | 23.35 | 14.80 | 11.16 | 18.86 | 16.89 | 10.02 | 5.39 | 1.19 | 3.87 | 3.89 | 16.82 |
Related Pages for Supriya Lifescience
Additional stock information and data for SUPRIYA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 1,112 | 921 | 820 | 735 | 446 | 336 | 253 | 245 | 241 | 231 | 176 |
| Current Assets | 437 | 398 | 465 | 498 | 266 | 196 | 133 | 120 | 115 | 129 | 103 |
| Fixed Assets | 453 | 310 | 262 | 190 | 100 | 99 | 85 | 91 | 89 | 76 | 61 |
| Capital Work in Progress | 148 | 149 | 68 | 43 | 79 | 40 | 35 | 34 | 36 | 25 | 11 |
| Investments | 63 | 64 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 448 | 399 | 466 | 502 | 267 | 197 | 133 | 120 | 117 | 131 | 104 |
| LIABILITIES | |||||||||||
| Total Liabilities | 1,112 | 921 | 820 | 735 | 446 | 336 | 253 | 245 | 241 | 231 | 176 |
| Current Liabilities | 33 | 29 | 25 | 19 | 31 | 32 | 24 | 45 | 51 | 39 | 23 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 997 | 815 | 700 | 616 | 269 | 149 | 94 | 55 | 46 | 42 | 37 |
| Share Capital | 16 | 16 | 16 | 16 | 15 | 15 | 15 | 15 | 15 | 15 | 5 |
| Reserves & Surplus | 981 | 799 | 683 | 600 | 254 | 134 | 79 | 40 | 31 | 26 | 33 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 165 | 113 | 64 | 49 | 76 | 117 | 49 | 28 | 27 | 14 | -6 |
| Investing Activities | -152 | -174 | -124 | -60 | -47 | -25 | 5 | -5 | -27 | -33 | -23 |
| Financing Activities | -8 | -22 | -10 | 150 | -15 | -29 | -50 | -20 | -2 | 21 | 30 |
| Net Cash Flow | 4 | -83 | -70 | 139 | 15 | 62 | 4 | 3 | -2 | 2 | 1 |